Patent · US Active

Anti-PMEL17 antibodies and immunoconjugates

US9056910B2 · kind B2 · utility

11Cited by
118References
67Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2013
Grant dateJun 16, 2015
Priority date—
Expiry dateApr 30, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/77
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.